Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

British Journal of Cancer 115, 188 (12 July 2016). doi:10.1038/bjc.2016.185

Authors: E Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, Robert El-Maraghi, Wen Wee Ma, Michele Reni, Marion Harris, Robert Whorf, Helen Liu, Jack Shiansong Li, Victoria Manax, Alfredo Romano, Brian Lu & David Goldstein

from Cancer via ola Kala on Inoreader http://ift.tt/29vHCZO
via IFTTT